Shares of Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH) are skyrocketing 51.61% in pre-market trading on Thursday following the release of the company's impressive second-quarter financial results and an upward revision of its 2025 outlook. The healthcare services provider significantly outperformed analyst expectations, demonstrating robust growth across key financial metrics.

For the second quarter, Aveanna reported earnings per share of $0.18, substantially beating the analyst consensus estimate of $0.04. This represents a remarkable 1700% increase from the $0.01 per share reported in the same period last year. The company's quarterly revenue soared to $589.6 million, surpassing the analyst estimate of $535.37 million by 10.12% and marking a 16.75% year-over-year growth. Net income for the quarter surged to $27.0 million, representing a substantial 94.3% rise from the previous year.

Adding to the positive sentiment, Aveanna has raised its full-year 2025 revenue guidance to over $2.3 billion, up from the previous estimate of more than $2.15 billion. The company also increased its 2025 Adjusted EBITDA guidance to greater than $270 million, revised upwards from the earlier projection of more than $207 million. This optimistic outlook, coupled with the strong Q2 performance, appears to be driving investor enthusiasm and contributing to the significant pre-market stock price surge. The company's acquisition of Thrive Skilled Pediatric Care was highlighted as a strategic move to enhance its market presence and expand its core services in pediatric healthcare.